作者：
Luciana,Melo Garcia [1]
;
Achintyan,Gangadharan [2]
;
Pinaki,Banerjee [3]
;
Ye,Li [3]
;
Andy G X,Zeng [4]
;
Hind,Rafei [3]
;
Paul,Lin [3]
;
Bijender,Kumar [3]
;
Sunil,Acharya [3]
;
May,Daher [3]
;
Luis,Muniz-Feliciano [3]
;
Gary M,Deyter [3]
;
Gabriel,Dominguez [3]
;
Jeong Min,Park [3]
;
Francia,Reyes Silva [3]
;
Ana Karen,Nunez Cortes [3]
;
Rafet,Basar [3]
;
Nadima,Uprety [3]
;
Mayra,Shanley [3]
;
Mecit,Kaplan [3]
;
Enli,Liu [3]
;
Elizabeth J,Shpall [3]
;
Katayoun,Rezvani [5]
作者单位：
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada; Hematology-Oncology Service, CHU de Québec - Université Laval, Quebec City, QC G1V 0A6, Canada.
[1]
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Cancer Biology PhD Program, University of South Florida, Tampa, FL 33616, USA.
[2]
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
[3]
Princess Margaret Cancer Center, University Healthy Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
[4]
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: krezvani@mdanderson.org.
[5]
DOI
10.1016/j.celrep.2024.115122
PMID
39754720
发布时间
2025-01-04
换一批
换一批
